Gubra to increase research focus on obesity candidate
Obesity and its treatments have been this year’s big topic of conversation, and it has also received a lot of attention at Danish research and biotech company Gubra, which this year will focus even more on the development of drug candidates for the treatment of obesity.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Gubra ends research agreement with Silence Therapeutics
For subscribers